Drug Database · Clinicians

Dextromethorphan + Guaifenesin

Also known as: guaiphenesin (former British name, for guaifenesin)

Brands (10) Robitussin DM, Biotuss, Dextrocare Plus…Show all

US brand (reference label): Mucus Relief DM; not a Philippine-registered brand.

Expectorant US FDA class
Antitussive/Expectorant; Expectorant/Antitussive; and others PH FDA category
Fixed-dose combination.

Rx · Prescription drugOTC · Over-the-counter13 PH products
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID d02f32c1-716e-4753-abba-ff97c4dc9e22, version date October 22, 2026 (Mucus Relief DM · Chain Drug Marketing Association, Inc.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial…
US FDA label
Full indications and usage US FDA label

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get to sleep

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions do not take more than directed do not take more than 6 doses in any 24-hour period mL = milliliter only use the dose cup provided dose as follows or as directed by a doctor adults and children 12 years and over: 20 mL in dosing cup provided every 4 hours children under 12 years: do not use

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 5 mg/50 mg per 5 mL, 10 mg/50 mg per 5 mL, 15 mg/100 mg per 5 mL, 100 mg/15 mg per 5 mL, 200 mg/30 mg per 10 mL

Registered products in the Philippines

13 products registered with the Food and Drug Administration (FDA) Philippines list Dextromethorphan + Guaifenesin as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Guiafenesin + Dextromethorphan Hydrobromide (2 products). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products13
Philippine FDA-registered products for Dextromethorphan + Guaifenesin
Package insert
BiotussDextromethorphan Hydrobromide + Guaifenesin
15mg /100mg per 5 mL Syrup (Cherry Flavor)Boston Round Bottle x 60 mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.Bulacan
—
DRP-3101
Jul 12, 2031
Dextrocare PlusDextromethorphan Hydrobromide + Guaifenesin
15mg/100mg per 5mL Syrup (Cherry Flavor)Boston Round Bottle x 60mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.Bulacan
Jaac Healthline Marketing
DRP-3101-02
Jul 12, 2031
FlemexDextromethorphan Hydrobromide + Guaifenesin
5 mg/50 mg per 5 mL SyrupAmber Glass Bottle X 60 mL (Box of 1's); Amber Glass Bottle X 15 mL (Physician's Sample) (Box of 1's)
OTC
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma Inc.
DR-XY35351
Jan 29, 2029
GuadesynDextromethorphan Hydrobromide + Guaifenesin
15 mg/100 mg per 5 mL SyrupBoston Round Amber Bottle x 60mL & 120mL (Box of 1's)
OTC
Sydenham Laboratories, Inc.Philippines
—
DRP-13252
Jan 11, 2028
HealthcareDextromethorphan Hydrochloride + Guaifenesin
15 mg/100 mg per 5 mL SyrupAmber bottle x 120 mL (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
—
DR-XY39937 (For Export Only)
Aug 17, 2031
MucotussDextromethorphan Hydrobromide + Guaifenesin
10 mg/50 mg per 5 mL SyrupAmber Glass Bottle x 60 mL and 120 mL (Box of 1's)
OTC
Drugmaker's Laboratories, Inc.Philippines
Trader: Terramedic, Inc.
DRP-8225
Mar 27, 2028
MucunavGuaifenesin + Dextromethorphan Hydrobromide
100mg/15mg per 5mL SyrupPET Amber Bottle x 120 mL (Box of 1's)
OTC
Opal Laboratories (Pvt.) LimitedPakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-17093-02
Sep 30, 2030
MucussinGuiafenesin + Dextromethorphan HydrobromideVariant spelling
100 mg/15 mg per 5 mL SyrupPET Amber Bottle x 120 mL (Box of 1's)
OTC
Opal Laboratories (Pvt.) LimitedPakistan
Accesspoint International Trading
DRP-17093
Sep 30, 2030
NoneGuaifenesin + Dextromethorphan Hydrobromide
100 mg/15 mg per 5 mL SyrupAmber Glass Bottle x 60 mL
Rx
Hizon Laboratories, Inc.Philippines
—
DR-XY33542
Jul 6, 2027
NoneGuiafenesin + Dextromethorphan HydrobromideVariant spelling
100 mg/15 mg per 5 mL SyrupPET Amber Bottle x 120 mL (Box of 1's)
OTC
Opal Laboratories (Pvt.) LimitedPakistan
Reta DrugImporter: Accesspoint International Trading Inc.
DRP-17093-01
Sep 30, 2030
Robitussin DMDextromethorphan Hydrobromide + Guaifenesin
15 mg/100 mg per 5 mL SyrupAmber Glass Bottle with Aluminum Cap with Laminated FPE liner x 60 mL (Box of 1's); Amber Glass Bottle with Aluminum Cap with Laminated FPE liner x 120 mL (Box of 1's)
OTC
Interphil Laboratories, Inc.Philippines
Trader: GlaxoSmithKline Consumer Healthcare Philippines, Inc.
DR-8402-L
May 25, 2028
Robitussin DMGuaifenesin + Dextromethorphan Hydrobromide
200 mg/30 mg per 10 mL SyrupGlass Amber Bottle x 100 mL and 200 mL (Box of 1's)
Rx
Interphil Laboratories, Inc.Philippines
—
DR-XY31185 (For Export Only)
Oct 17, 2030
SyguadexDextromethorphan Hydrobromide + Guaifenesin
15 mg/100 mg per 5 mL SyrupBoston Round Amber Bottle x 60mL & 120mL (Box of 1's)
OTC
Sydenham Laboratories, Inc.Philippines
Sydenham Laboratories, Inc.
DRP-13253
Jan 11, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough that occurs with too much phlegm (mucus) Stop use and ask a doctor if cough persists more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Mucus Relief DM · Chain Drug Marketing Association, Inc. [US FDA-approved label, version 3, October 22, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d02f32c1-716e-4753-abba-ff97c4dc9e22
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .